Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal Charcoal Tablets for primary gout with hyperuricemia
ChiCTR2000034138Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of activated charcoal and febuxostat in idiopathic gout and hyperuricemia (4 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Serum uric acid. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
activated charcoalfebuxostat
03
Conditions
idiopathic gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR2000034138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034138.